XNIF:LSE:LSE-Xtrackers Nifty 50 Swap UCITS ETF 1C (GBX)

ETF | Others |

Last Closing

USD 20610.5

Change

+77.00 (+0.37)%

Market Cap

USD 0.19B

Volume

105.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-2.60 (-1.25%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.02 (-0.08%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 640.06B
0R1I:LSE NVIDIA Corp.

-6.15 (-4.33%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.06 (-0.18%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

+0.90 (+1.27%)

USD 266.08B
0QZO:LSE 0QZO

+1.00 (+0.90%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.70 (-3.12%)

USD 202.26B
0R24:LSE Intel Corp.

-0.56 (-2.75%)

USD 196.14B

ETFs Containing XNIF:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.38% 31% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.38% 30% F 36% F
Trailing 12 Months  
Capital Gain 0.40% 27% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.40% 25% F 39% F
Trailing 5 Years  
Capital Gain 105.76% 87% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 105.76% 85% B 85% B
Average Annual (5 Year Horizon)  
Capital Gain 14.37% 75% C 77% C+
Dividend Return 14.37% 74% C 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.86% 54% F 71% C-
Risk Adjusted Return 111.73% 94% A 96% N/A
Market Capitalization 0.19B 60% D- 34% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike